# An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005

> **NCT07442149** · PHASE1 · COMPLETED · sponsor: **Alumis Inc** · enrollment: 135 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** A-005
- **DRUG:** A-005
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07442149
- **Lead sponsor:** Alumis Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-22
- **Primary completion:** 2024-12-18
- **Final completion:** 2024-12-18
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07442149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07442149, "An Investigational Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of A-005". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07442149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*